Global Systemic Aspergillosis and Systemic Candidiasis Treatment Market Growth (Status and Outlook) 2023-2029
LPI (LP Information)' newest research report, the “Systemic Aspergillosis and Systemic Candidiasis Treatment Industry Forecast” looks at past sales and reviews total world Systemic Aspergillosis and Systemic Candidiasis Treatment sales in 2022, providing a comprehensive analysis by region and market sector of projected Systemic Aspergillosis and Systemic Candidiasis Treatment sales for 2023 through 2029. With Systemic Aspergillosis and Systemic Candidiasis Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Systemic Aspergillosis and Systemic Candidiasis Treatment industry.
This Insight Report provides a comprehensive analysis of the global Systemic Aspergillosis and Systemic Candidiasis Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Systemic Aspergillosis and Systemic Candidiasis Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Systemic Aspergillosis and Systemic Candidiasis Treatment market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Systemic Aspergillosis and Systemic Candidiasis Treatment and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Systemic Aspergillosis and Systemic Candidiasis Treatment.
The global Systemic Aspergillosis and Systemic Candidiasis Treatment market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Systemic Aspergillosis and Systemic Candidiasis Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Systemic Aspergillosis and Systemic Candidiasis Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Systemic Aspergillosis and Systemic Candidiasis Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Systemic Aspergillosis and Systemic Candidiasis Treatment players cover Basilea Pharmaceutica, Astellas Pharma, Ferrer International, Pacgen Life Science, NovaDigm Therapeutics, Cidara Therapeutics, Amplyx Pharmaceuticals, Pfizer and Novartis, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Systemic Aspergillosis and Systemic Candidiasis Treatment market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Voriconazole
Liposomal Amphotericin B
Systemic Oral Azoles
Topical Antifungal Agents
Others
Segmentation by application
Chronic Pulmonary Aspergillosis (CPA)
Allergic Bronchopulmonary Aspergillosis (ABPA)
Gastrointestinal Candidiasis
Genitourinary Tract Candidiasis
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Basilea Pharmaceutica
Astellas Pharma
Ferrer International
Pacgen Life Science
NovaDigm Therapeutics
Cidara Therapeutics
Amplyx Pharmaceuticals
Pfizer
Novartis
Sanofi
Merck
Bayer
GlaxoSmithKline
Abbott
Cipla
Please note: The report will take approximately 2 business days to prepare and deliver.
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Years Considered
- 1.3 Research Objectives
- 1.4 Market Research Methodology
- 1.5 Research Process and Data Source
- 1.6 Economic Indicators
- 1.7 Currency Considered
- 1.8 Market Estimation Caveats
- 2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size 2018-2029
- 2.1.2 Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size CAGR by Region 2018 VS 2022 VS 2029
- 2.2 Systemic Aspergillosis and Systemic Candidiasis Treatment Segment by Type
- 2.2.1 Voriconazole
- 2.2.2 Liposomal Amphotericin B
- 2.2.3 Systemic Oral Azoles
- 2.2.4 Topical Antifungal Agents
- 2.2.5 Others
- 2.3 Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size by Type
- 2.3.1 Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size CAGR by Type (2018 VS 2022 VS 2029)
- 2.3.2 Global Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size Market Share by Type (2018-2023)
- 2.4 Systemic Aspergillosis and Systemic Candidiasis Treatment Segment by Application
- 2.4.1 Chronic Pulmonary Aspergillosis (CPA)
- 2.4.2 Allergic Bronchopulmonary Aspergillosis (ABPA)
- 2.4.3 Gastrointestinal Candidiasis
- 2.4.4 Genitourinary Tract Candidiasis
- 2.4.5 Others
- 2.5 Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size by Application
- 2.5.1 Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size CAGR by Application (2018 VS 2022 VS 2029)
- 2.5.2 Global Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size Market Share by Application (2018-2023)
- 3 Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size by Player
- 3.1 Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size Market Share by Players
- 3.1.1 Global Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue by Players (2018-2023)
- 3.1.2 Global Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue Market Share by Players (2018-2023)
- 3.2 Global Systemic Aspergillosis and Systemic Candidiasis Treatment Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
- 4 Systemic Aspergillosis and Systemic Candidiasis Treatment by Regions
- 4.1 Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size by Regions (2018-2023)
- 4.2 Americas Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size Growth (2018-2023)
- 4.3 APAC Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size Growth (2018-2023)
- 4.4 Europe Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size Growth (2018-2023)
- 4.5 Middle East & Africa Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size Growth (2018-2023)
- 5 Americas
- 5.1 Americas Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size by Country (2018-2023)
- 5.2 Americas Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size by Type (2018-2023)
- 5.3 Americas Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size by Application (2018-2023)
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Brazil
- 6 APAC
- 6.1 APAC Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size by Region (2018-2023)
- 6.2 APAC Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size by Type (2018-2023)
- 6.3 APAC Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size by Application (2018-2023)
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 7 Europe
- 7.1 Europe Systemic Aspergillosis and Systemic Candidiasis Treatment by Country (2018-2023)
- 7.2 Europe Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size by Type (2018-2023)
- 7.3 Europe Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size by Application (2018-2023)
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 8 Middle East & Africa
- 8.1 Middle East & Africa Systemic Aspergillosis and Systemic Candidiasis Treatment by Region (2018-2023)
- 8.2 Middle East & Africa Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size by Type (2018-2023)
- 8.3 Middle East & Africa Systemic Aspergillosis and Systemic Candidiasis Treatment Market Size by Application (2018-2023)
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
- 9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers & Growth Opportunities
- 9.2 Market Challenges & Risks
- 9.3 Industry Trends
- 10 Global Systemic Aspergillosis and Systemic Candidiasis Treatment Market Forecast
- 10.1 Global Systemic Aspergillosis and Systemic Candidiasis Treatment Forecast by Regions (2024-2029)
- 10.1.1 Global Systemic Aspergillosis and Systemic Candidiasis Treatment Forecast by Regions (2024-2029)
- 10.1.2 Americas Systemic Aspergillosis and Systemic Candidiasis Treatment Forecast
- 10.1.3 APAC Systemic Aspergillosis and Systemic Candidiasis Treatment Forecast
- 10.1.4 Europe Systemic Aspergillosis and Systemic Candidiasis Treatment Forecast
- 10.1.5 Middle East & Africa Systemic Aspergillosis and Systemic Candidiasis Treatment Forecast
- 10.2 Americas Systemic Aspergillosis and Systemic Candidiasis Treatment Forecast by Country (2024-2029)
- 10.2.1 United States Systemic Aspergillosis and Systemic Candidiasis Treatment Market Forecast
- 10.2.2 Canada Systemic Aspergillosis and Systemic Candidiasis Treatment Market Forecast
- 10.2.3 Mexico Systemic Aspergillosis and Systemic Candidiasis Treatment Market Forecast
- 10.2.4 Brazil Systemic Aspergillosis and Systemic Candidiasis Treatment Market Forecast
- 10.3 APAC Systemic Aspergillosis and Systemic Candidiasis Treatment Forecast by Region (2024-2029)
- 10.3.1 China Systemic Aspergillosis and Systemic Candidiasis Treatment Market Forecast
- 10.3.2 Japan Systemic Aspergillosis and Systemic Candidiasis Treatment Market Forecast
- 10.3.3 Korea Systemic Aspergillosis and Systemic Candidiasis Treatment Market Forecast
- 10.3.4 Southeast Asia Systemic Aspergillosis and Systemic Candidiasis Treatment Market Forecast
- 10.3.5 India Systemic Aspergillosis and Systemic Candidiasis Treatment Market Forecast
- 10.3.6 Australia Systemic Aspergillosis and Systemic Candidiasis Treatment Market Forecast
- 10.4 Europe Systemic Aspergillosis and Systemic Candidiasis Treatment Forecast by Country (2024-2029)
- 10.4.1 Germany Systemic Aspergillosis and Systemic Candidiasis Treatment Market Forecast
- 10.4.2 France Systemic Aspergillosis and Systemic Candidiasis Treatment Market Forecast
- 10.4.3 UK Systemic Aspergillosis and Systemic Candidiasis Treatment Market Forecast
- 10.4.4 Italy Systemic Aspergillosis and Systemic Candidiasis Treatment Market Forecast
- 10.4.5 Russia Systemic Aspergillosis and Systemic Candidiasis Treatment Market Forecast
- 10.5 Middle East & Africa Systemic Aspergillosis and Systemic Candidiasis Treatment Forecast by Region (2024-2029)
- 10.5.1 Egypt Systemic Aspergillosis and Systemic Candidiasis Treatment Market Forecast
- 10.5.2 South Africa Systemic Aspergillosis and Systemic Candidiasis Treatment Market Forecast
- 10.5.3 Israel Systemic Aspergillosis and Systemic Candidiasis Treatment Market Forecast
- 10.5.4 Turkey Systemic Aspergillosis and Systemic Candidiasis Treatment Market Forecast
- 10.5.5 GCC Countries Systemic Aspergillosis and Systemic Candidiasis Treatment Market Forecast
- 10.6 Global Systemic Aspergillosis and Systemic Candidiasis Treatment Forecast by Type (2024-2029)
- 10.7 Global Systemic Aspergillosis and Systemic Candidiasis Treatment Forecast by Application (2024-2029)
- 11 Key Players Analysis
- 11.1 Basilea Pharmaceutica
- 11.1.1 Basilea Pharmaceutica Company Information
- 11.1.2 Basilea Pharmaceutica Systemic Aspergillosis and Systemic Candidiasis Treatment Product Offered
- 11.1.3 Basilea Pharmaceutica Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue, Gross Margin and Market Share (2018-2023)
- 11.1.4 Basilea Pharmaceutica Main Business Overview
- 11.1.5 Basilea Pharmaceutica Latest Developments
- 11.2 Astellas Pharma
- 11.2.1 Astellas Pharma Company Information
- 11.2.2 Astellas Pharma Systemic Aspergillosis and Systemic Candidiasis Treatment Product Offered
- 11.2.3 Astellas Pharma Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue, Gross Margin and Market Share (2018-2023)
- 11.2.4 Astellas Pharma Main Business Overview
- 11.2.5 Astellas Pharma Latest Developments
- 11.3 Ferrer International
- 11.3.1 Ferrer International Company Information
- 11.3.2 Ferrer International Systemic Aspergillosis and Systemic Candidiasis Treatment Product Offered
- 11.3.3 Ferrer International Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue, Gross Margin and Market Share (2018-2023)
- 11.3.4 Ferrer International Main Business Overview
- 11.3.5 Ferrer International Latest Developments
- 11.4 Pacgen Life Science
- 11.4.1 Pacgen Life Science Company Information
- 11.4.2 Pacgen Life Science Systemic Aspergillosis and Systemic Candidiasis Treatment Product Offered
- 11.4.3 Pacgen Life Science Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue, Gross Margin and Market Share (2018-2023)
- 11.4.4 Pacgen Life Science Main Business Overview
- 11.4.5 Pacgen Life Science Latest Developments
- 11.5 NovaDigm Therapeutics
- 11.5.1 NovaDigm Therapeutics Company Information
- 11.5.2 NovaDigm Therapeutics Systemic Aspergillosis and Systemic Candidiasis Treatment Product Offered
- 11.5.3 NovaDigm Therapeutics Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue, Gross Margin and Market Share (2018-2023)
- 11.5.4 NovaDigm Therapeutics Main Business Overview
- 11.5.5 NovaDigm Therapeutics Latest Developments
- 11.6 Cidara Therapeutics
- 11.6.1 Cidara Therapeutics Company Information
- 11.6.2 Cidara Therapeutics Systemic Aspergillosis and Systemic Candidiasis Treatment Product Offered
- 11.6.3 Cidara Therapeutics Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue, Gross Margin and Market Share (2018-2023)
- 11.6.4 Cidara Therapeutics Main Business Overview
- 11.6.5 Cidara Therapeutics Latest Developments
- 11.7 Amplyx Pharmaceuticals
- 11.7.1 Amplyx Pharmaceuticals Company Information
- 11.7.2 Amplyx Pharmaceuticals Systemic Aspergillosis and Systemic Candidiasis Treatment Product Offered
- 11.7.3 Amplyx Pharmaceuticals Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue, Gross Margin and Market Share (2018-2023)
- 11.7.4 Amplyx Pharmaceuticals Main Business Overview
- 11.7.5 Amplyx Pharmaceuticals Latest Developments
- 11.8 Pfizer
- 11.8.1 Pfizer Company Information
- 11.8.2 Pfizer Systemic Aspergillosis and Systemic Candidiasis Treatment Product Offered
- 11.8.3 Pfizer Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue, Gross Margin and Market Share (2018-2023)
- 11.8.4 Pfizer Main Business Overview
- 11.8.5 Pfizer Latest Developments
- 11.9 Novartis
- 11.9.1 Novartis Company Information
- 11.9.2 Novartis Systemic Aspergillosis and Systemic Candidiasis Treatment Product Offered
- 11.9.3 Novartis Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue, Gross Margin and Market Share (2018-2023)
- 11.9.4 Novartis Main Business Overview
- 11.9.5 Novartis Latest Developments
- 11.10 Sanofi
- 11.10.1 Sanofi Company Information
- 11.10.2 Sanofi Systemic Aspergillosis and Systemic Candidiasis Treatment Product Offered
- 11.10.3 Sanofi Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue, Gross Margin and Market Share (2018-2023)
- 11.10.4 Sanofi Main Business Overview
- 11.10.5 Sanofi Latest Developments
- 11.11 Merck
- 11.11.1 Merck Company Information
- 11.11.2 Merck Systemic Aspergillosis and Systemic Candidiasis Treatment Product Offered
- 11.11.3 Merck Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue, Gross Margin and Market Share (2018-2023)
- 11.11.4 Merck Main Business Overview
- 11.11.5 Merck Latest Developments
- 11.12 Bayer
- 11.12.1 Bayer Company Information
- 11.12.2 Bayer Systemic Aspergillosis and Systemic Candidiasis Treatment Product Offered
- 11.12.3 Bayer Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue, Gross Margin and Market Share (2018-2023)
- 11.12.4 Bayer Main Business Overview
- 11.12.5 Bayer Latest Developments
- 11.13 GlaxoSmithKline
- 11.13.1 GlaxoSmithKline Company Information
- 11.13.2 GlaxoSmithKline Systemic Aspergillosis and Systemic Candidiasis Treatment Product Offered
- 11.13.3 GlaxoSmithKline Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue, Gross Margin and Market Share (2018-2023)
- 11.13.4 GlaxoSmithKline Main Business Overview
- 11.13.5 GlaxoSmithKline Latest Developments
- 11.14 Abbott
- 11.14.1 Abbott Company Information
- 11.14.2 Abbott Systemic Aspergillosis and Systemic Candidiasis Treatment Product Offered
- 11.14.3 Abbott Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue, Gross Margin and Market Share (2018-2023)
- 11.14.4 Abbott Main Business Overview
- 11.14.5 Abbott Latest Developments
- 11.15 Cipla
- 11.15.1 Cipla Company Information
- 11.15.2 Cipla Systemic Aspergillosis and Systemic Candidiasis Treatment Product Offered
- 11.15.3 Cipla Systemic Aspergillosis and Systemic Candidiasis Treatment Revenue, Gross Margin and Market Share (2018-2023)
- 11.15.4 Cipla Main Business Overview
- 11.15.5 Cipla Latest Developments
- 12 Research Findings and Conclusion
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook